Brief: Revance Prices $100 Mln Public Offering

Revance Therapeutics

04/03/2024 14:27

March 4 (Reuters) - Revance Therapeutics Inc  RVNC.O :
    * REVANCE ANNOUNCES PRICING OF $100.0 MILLION PUBLIC
OFFERING OF
COMMON STOCK
    * REVANCE THERAPEUTICS INC - PRICING OF AN UNDERWRITTEN
PUBLIC
OFFERING OF 16 MILLION SHARES OF ITS COMMON STOCK
    * REVANCE THERAPEUTICS INC: SHARES OF COMMON STOCK ARE BEING
OFFERED AT A PUBLIC OFFERING PRICE OF $6.25 PER SHARE

Source text for Eikon:  ID:nBw2JWgdDa 
Further company coverage:  RVNC.O 

 ((Reuters.Briefs@thomsonreuters.com;))